| Announce Date | 12/12/2025 |
| EPS Normalized Actual | $0.07 (Beat by $0.05) |
| EPS GAAP Actual | $0.07 (Beat by $0.05) |
| Revenue Actual | $0.00761B |
| Revenue Surprise | Beat by $7.61M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.08 |
| EPS GAAP Estimate | $0.08 |
| Revenue Estimate | $0.0099B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jul 2027 | 0.18 | 17.44 | 0.18 | 0.18 | 1 |
| Jul 2026 | 0.32 | 9.81 | 0.32 | 0.32 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.0605 | -0.0195 | 0.00761B | 5.47% | -1.69M |
| FQ3 2025 (Jul 2025) | -0.0416 | -0.1716 | 0.007468B | -1.51% | -1.33M |
| FQ2 2025 (Apr 2025) | 0.01 | -0.11 | 0.007757B | 1.28% | -0.64M |
| FQ1 2025 (Jan 2025) | 0.0244 | -0.1056 | 0.006979B | -11.35% | -1.92M |
| FQ4 2024 (Oct 2024) | -0.0241 | -0.0241 | 0.007194B | 1.57% | 7.19M |
| FQ3 2024 (Jul 2024) | -0.0028 | -0.0028 | 0.007581B | 12.52% | 7.58M |
| FQ2 2024 (Apr 2024) | 0.008 | 0.008 | 0.007658B | 100% | 7.66M |
| FQ1 2024 (Jan 2024) | -0.66 | -0.66 | 0.007771B | 10.14% | 7.77M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
0.08
Consensus Revenue Estimates
0.0099B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 0.05 | -- | 0.05 | 0.05 | 1 |
| FQ2 2027 (Apr 2027) | 0.05 | -- | 0.05 | 0.05 | 1 |
| FQ1 2027 (Jan 2027) | 0.05 | -- | 0.05 | 0.05 | 1 |
| FQ4 2026 (Oct 2026) | 0.04 | -51.25 | 0.04 | 0.04 | 1 |
| FQ3 2026 (Jul 2026) | 0.08 | 152 | 0.08 | 0.08 | 0 |
| FQ2 2026 (Apr 2026) | 0.08 | 87.5 | 0.08 | 0.08 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ2 2027 (Apr 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ1 2027 (Jan 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ4 2026 (Oct 2026) | 0.01B | -7.18 | 0.01B | 0.01B | 1 |
| FQ3 2026 (Jul 2026) | 0.01B | 29.55 | 0.01B | 0.01B | 0 |
| FQ2 2026 (Apr 2026) | 0.01B | 24.69 | 0.01B | 0.01B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 0.08 | 0.0605 | -0.0195 | -32.23% |
| FQ3 2025 (Jul 2025) | 0.13 | -0.0416 | -0.1716 | 412.5% |
| FQ2 2025 (Apr 2025) | 0.12 | 0.01 | -0.11 | -1100% |
| FQ1 2025 (Jan 2025) | 0.13 | 0.0244 | -0.1056 | -432.79% |
| FQ4 2024 (Oct 2024) | -0.0241 | -0.0241 | 100% | |
| FQ3 2024 (Jul 2024) | -0.0028 | -0.0028 | 100% | |
| FQ2 2024 (Apr 2024) | 0.008 | 0.008 | 100% | |
| FQ1 2024 (Jan 2024) | -0.66 | -0.66 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.01B | $0.01B | $-1.69M | -22.21% |
| FQ3 2025 (Jul 2025) | $0.01B | $0.01B | $-1.33M | -17.84% |
| FQ2 2025 (Apr 2025) | $0.01B | $0.01B | $-0.64M | -8.29% |
| FQ1 2025 (Jan 2025) | $0.01B | $0.01B | $-1.92M | -27.53% |
| FQ4 2024 (Oct 2024) | $0B | $0.01B | $7.19M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.01B | $7.58M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.01B | $7.66M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.01B | $7.77M | 100% |